Suchergebnisse - "De Luca, Annamaria"

PubPharm (9)

1

Ion channels as biomarkers of altered myogenesis in myofiber precursors of Duchenne muscular dystrophy

enthalten in: Annals of the New York Academy of Sciences | 2024

von Cerchiara, A. | Imbrici, P. | Quarta, R. | +6

2

Ryanodine channel complex stabilizer compound S48168/ARM210 as a disease modifier in dystrophin-deficient mdx mice : proof-of-concept study and independent validation of efficacy

enthalten in: FASEB journal : official publication of the Federation of American Societies for Experimental Biology | 2018

von Capogrosso, R. | Mantuano, P. | Uaesoontrachoon, K. | +15

3

Isolation and characterization of neural stem cells from dystrophic mdx mouse

enthalten in: Experimental cell research | 2016

von Annese, T. | Corsi, P. | Ruggieri, S. | +11

4

Pre-clinical drug tests in the mdx mouse as a model of dystrophinopathies : an overview

enthalten in: Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology | 2012

von De Luca, A.

5

Enhancing translation : guidelines for standard pre-clinical experiments in mdx mice

enthalten in: Neuromuscular disorders : NMD | 2012

von Willmann, R. | De Luca, A. | Benatar, M. | +5

6

Gentamicin treatment in exercised mdx mice : Identification of dystrophin-sensitive pathways and evaluation of efficacy in work-loaded dystrophic muscle

enthalten in: Neurobiology of disease | 2008

von De Luca, A. | Nico, B. | Rolland, J. | +12

7

Overactivity of exercise-sensitive cation channels and their impaired modulation by IGF-1 in mdx native muscle fibers : beneficial effect of pentoxifylline

enthalten in: Neurobiology of disease | 2006

von Rolland, J. | De Luca, A. | Burdi, R. | +3

8

Prednisone in dystrophin-deficient Caernorabditis elegans

enthalten in: Neuromuscular disorders : NMD | 2004

von De Luca, A.

CommentOn: Neuromuscul Disord. 2004 Jun;14(6):365-70. - PMID 15145337

9

Pre-clinical trials in Duchenne dystrophy : what animal models can tell us about potential drug effectiveness

enthalten in: Neuromuscular disorders : NMD | 2002

von De Luca, A. | Pierno, S. | Liantonio, A. | +1

1
[1]